AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33550254 — intervention group
Group type: COMPARATOR
Intervention: MedDiet
Number of subjects: 108
Study 33550254 — intervention group
Group type: COMPARATOR
Intervention: MedDiet+PA
Number of subjects: 108
Study 33550254 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 108
Study 33550302 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchoscopic lung volume reduction (BLVR)
Number of subjects: 20
Study 33550302 — intervention group
Group type: COMPARATOR
Intervention: Before BLVR
Number of subjects: 20
Study 33550302 — intervention group
Group type: EXPERIMENTAL
Intervention: After BLVR
Number of subjects: 20
Study 33550636 — intervention group
Group type: EXPERIMENTAL
Intervention: UBDRS seizure score
Number of subjects: 20
Study 33550636 — intervention group
Group type: EXPERIMENTAL
Intervention: Seizures
Number of subjects: 20
Study 33550636 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC and CSF NEFL
Number of subjects: 20
Study 33550824 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide, dosage and duration not specified
Number of subjects: 0
Study 33550824 — intervention group
Group type: COMPARATOR
Intervention: Control group, treatment not specified
Number of subjects: 0
Study 33550846 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluid testing (OFT) - supervised testing
Number of subjects: 813
Study 33550846 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluid testing (OFT) - unsupervised testing
Number of subjects: 813
Study 33550846 — intervention group
Group type: COMPARATOR
Intervention: Before intervention
Number of subjects: 813
Study 33550846 — intervention group
Group type: EXPERIMENTAL
Intervention: During intervention
Number of subjects: 813
Study 33550890 — intervention group
Group type: EXPERIMENTAL
Intervention: K-Nearest Neighbors (K-NNs) classification model
Number of subjects: 140
Study 33550890 — intervention group
Group type: EXPERIMENTAL
Intervention: Binomial logistic regression classification model
Number of subjects: 140
Study 33550890 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) classification model
Number of subjects: 140
Study 33550890 — intervention group
Group type: EXPERIMENTAL
Intervention: Naïve Bayes classification model
Number of subjects: 140
Study 33550890 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensemble model
Number of subjects: 140
Study 33551075 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlling Nutritional Status score
Number of subjects: 1927
Study 33551075 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic Nutritional Index
Number of subjects: 1927
Study 33551075 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Nutritional Risk Index
Number of subjects: 1927
Study 33551075 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlling Nutritional Status score + European System for Cardiac Operative Risk Evaluation II
Number of subjects: 1927
Study 33551075 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of malnutrition (as per Kaplan-Meier survival curve)
Number of subjects: 1927
Study 33551218 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet (KD)
Number of subjects: 59
Study 33551218 — intervention group
Group type: COMPARATOR
Intervention: Standard Diet (SD)
Number of subjects: 59
Study 33551398 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravascular lithotripsy (IVL) treatment
Number of subjects: 64
Study 33551398 — intervention group
Group type: COMPARATOR
Intervention: Control group (historical IVL control)
Number of subjects: 64
Study 33551777 — intervention group
Group type: EXPERIMENTAL
Intervention: BCI-guided robot hand training
Number of subjects: 14
Study 33551948 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Photobiomodulation, details on dosage and duration not available
Number of subjects: 0
Study 33551974 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA ≤400 U
Number of subjects: 0
Study 33551992 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutetium 177-DOTATATE therapy
Number of subjects: 1
Study 33551992 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodic evaluation of TFTs
Number of subjects: 1
Study 33552568 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epidural/general anesthesia
Number of subjects: 50
Study 33552568 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 50
Study 33552568 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (combined and general anesthesia)
Number of subjects: 50
Study 33553232 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal resistance training protocol with adequate protein intake and leucine supplementation
Number of subjects: 0
Study 33553232 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33553233 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g of cinnamon added to oatmeal prepared with milk
Number of subjects: 0
Study 33553313 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.9-mm cryoprobes
Number of subjects: 216
Study 33553313 — intervention group
Group type: COMPARATOR
Intervention: 2.4-mm cryoprobes
Number of subjects: 216
Study 33553313 — intervention group
Group type: EXPERIMENTAL
Intervention: Both probes
Number of subjects: 216
Study 33553366 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant toripalimab plus chemotherapy
Number of subjects: 0
Study 33553366 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (NAC)
Number of subjects: 0
Study 33553651 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report of emergency department (ED) visits
Number of subjects: 169
Study 33553651 — intervention group
Group type: COMPARATOR
Intervention: Emergency Department Information Exchange (EDIE)
Number of subjects: 169
Study 33553651 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report of ED visits
Number of subjects: 169
Study 33553651 — intervention group
Group type: COMPARATOR
Intervention: EDIE
Number of subjects: 169
Study 33553800 — intervention group
Group type: EXPERIMENTAL
Intervention: RunIn3 program
Number of subjects: 530
Study 33553968 — intervention group
Group type: EXPERIMENTAL
Intervention: REP 2139-Ca and Pegylated Interferon (pegIFN)
Number of subjects: 11
Study 33553968 — intervention group
Group type: EXPERIMENTAL
Intervention: REP 2139-Ca monotherapy
Number of subjects: 11
Study 33553968 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up after therapy
Number of subjects: 11
Study 33553968 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety and tolerability
Number of subjects: 11
Study 33554038 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg intravenously every 3 weeks)
Number of subjects: 101
Study 33554038 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-C heterozygosity
Number of subjects: 101
Study 33554315 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Multiple System Atrophy Rating Scale (UMSARS)
Number of subjects: 0
Study 33554315 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert consensus assessment
Number of subjects: 0
Study 33554514 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-regional pro-adrenomedullin (MR-proADM)
Number of subjects: 657
Study 33554514 — intervention group
Group type: COMPARATOR
Intervention: SOFA score alone
Number of subjects: 657
Study 33554514 — intervention group
Group type: EXPERIMENTAL
Intervention: SOFA score + MR-proADM
Number of subjects: 657
Study 33554514 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-proADM threshold of 1.75 nmol/L
Number of subjects: 657
Study 33554732 — intervention group
Group type: EXPERIMENTAL
Intervention: CD44v6-NWN2.CAR T cells with LNGFR spacer
Number of subjects: 0
Study 33554732 — intervention group
Group type: EXPERIMENTAL
Intervention: Different LNGFR spacers
Number of subjects: 0
Study 33555033 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib 400 mg single oral dose
Number of subjects: 30
Study 33555033 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib 400 mg daily, 3 weeks on and 1 week off
Number of subjects: 30
Study 33555258 — intervention group
Group type: EXPERIMENTAL
Intervention: TeamSTEPPS intervention
Number of subjects: 80
Study 33555265 — intervention group
Group type: EXPERIMENTAL
Intervention: START (Suicide-specific cognitive behavioral intervention)
Number of subjects: 70
Study 33555265 — intervention group
Group type: EXPERIMENTAL
Intervention: START with mobile augmentation
Number of subjects: 70
Study 33555265 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 70
Study 33555272 — intervention group
Group type: EXPERIMENTAL
Intervention: RUNX2 targeting in immature and KMT2A-R T-ALL cells
Number of subjects: 0
Study 33555272 — intervention group
Group type: EXPERIMENTAL
Intervention: RUNX2 upregulation
Number of subjects: 0
Study 33555272 — intervention group
Group type: EXPERIMENTAL
Intervention: RUNX2 targeting
Number of subjects: 0
Study 33555272 — intervention group
Group type: EXPERIMENTAL
Intervention: RUNX2 regulation of CXCR4 signaling
Number of subjects: 0
Study 33555436 — intervention group
Group type: EXPERIMENTAL
Intervention: In-hospital treatment for COVID-19 in patients < 65 years
Number of subjects: 2676
Study 33555436 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to ICU and treatment with IMV in patients < 65 years
Number of subjects: 2676
Study 33555436 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of case fatality in young patients
Number of subjects: 2676
Study 33555436 — intervention group
Group type: COMPARATOR
Intervention: Comparison with elderly patients (≥ 65 years)
Number of subjects: 2676
Study 33555456 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm vertical compaction technique (WVT) with gutta percha and epoxy resin-based sealer (AH Plus Jet)
Number of subjects: 92
Study 33555456 — intervention group
Group type: COMPARATOR
Intervention: Sealer-based filling technique (SBT) with single cone gutta percha and calcium silicate-based sealer (EndoSequence BC Sealer)
Number of subjects: 92
Study 33555777 — intervention group
Group type: COMPARATOR
Intervention: No organ support (n = 15,001)
Number of subjects: 20608
Study 33555777 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive mechanical ventilation (n = 5,005; 24.3%)
Number of subjects: 20608
Study 33555777 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive mechanical ventilation only (n = 1,749)
Number of subjects: 20608
Study 33555777 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive mechanical ventilation, vasoactive drugs, and new renal replacement therapy (n = 655)
Number of subjects: 20608
Study 33555777 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal membrane oxygenation (n = 389)
Number of subjects: 20608
Study 33555777 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge home (no organ support)
Number of subjects: 20608
Study 33555777 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge home (invasive mechanical ventilation only)
Number of subjects: 20608
Study 33555777 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge home (invasive mechanical ventilation, vasoactive drugs, and renal replacement)
Number of subjects: 20608
Study 33555777 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge home (invasive mechanical ventilation, age > 74 years)
Number of subjects: 20608
Study 33555777 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital length of stay (mechanical ventilation)
Number of subjects: 20608
Study 33555777 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted interhospital variation in mortality (invasive mechanical ventilation)
Number of subjects: 20608
Study 33555780 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic corticosteroids
Number of subjects: 0
Study 33555780 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous thromboprophylaxis
Number of subjects: 0
Study 33555780 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine
Number of subjects: 0
Study 33555780 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (compared with other corticosteroids)
Number of subjects: 0
Study 33555780 — intervention group
Group type: COMPARATOR
Intervention: Convalescent plasma
Number of subjects: 0
Study 33555780 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic anticoagulation
Number of subjects: 0
Study 33555780 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir in nonventilated patients with severe COVID-19
Number of subjects: 0
Study 33555780 — intervention group
Group type: COMPARATOR
Intervention: Remdesivir in patients with critical COVID-19
Number of subjects: 0
Study 33555780 — intervention group
Group type: EXPERIMENTAL
Intervention: Awake prone positioning
Number of subjects: 0
Study 33556206 — intervention group
Group type: EXPERIMENTAL
Intervention: nucleic acid polymers and pegIFN
Number of subjects: 40
Study 33556347 — intervention group
Group type: EXPERIMENTAL
Intervention: Transthoracic echocardiography
Number of subjects: 29
Study 33556493 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care intervention (PC) including a single in-person outpatient palliative care consultation (OPCC) plus 6 weekly, PC nurse coach-led telehealth sessions.
Number of subjects: 208
Study 33556493 — intervention group
Group type: COMPARATOR
Intervention: Non-completers (those who did not attend the OPCC or completed <6 telehealth sessions).
Number of subjects: 208
Study 33556845 — intervention group
Group type: EXPERIMENTAL
Intervention: MAMAACT intervention (training session and two dialogue meetings for midwives, leaflet and mobile application for women)
Number of subjects: 48
Study 33556845 — intervention group
Group type: EXPERIMENTAL
Intervention: MAMAACT leaflet and app
Number of subjects: 48
Study 33556845 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwives' reflections on practice due to training sessions and dialogue meetings
Number of subjects: 48
Study 33556845 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwives' communication strategies
Number of subjects: 48
Study 33556845 — intervention group
Group type: EXPERIMENTAL
Intervention: Institutional structures and power relationships
Number of subjects: 48
Study 33556845 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwives' task loads and time resources
Number of subjects: 48
Study 33557591 — intervention group
Group type: EXPERIMENTAL
Intervention: hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma
Number of subjects: 0
Study 33557637 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg weekly
Number of subjects: 2677
Study 33557756 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma metabolomics-based biomarkers (ceramides, acyl-carnitines, fatty acids, galectin-3, adiponectin, apolipoprotein B/apolipoprotein A1 ratio)
Number of subjects: 1065
Study 33557756 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk prediction algorithm combining clinical characteristics with established and novel biomarkers
Number of subjects: 1065
Study 33557756 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up after 12 months
Number of subjects: 1065
Study 33557831 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-based screening
Number of subjects: 16
Study 33557831 — intervention group
Group type: COMPARATOR
Intervention: Tuberculin skin-based screening
Number of subjects: 16
Study 33557834 — intervention group
Group type: EXPERIMENTAL
Intervention: Andago (bodyweight unloading at 20%, 35%, and 50%)
Number of subjects: 18
Study 33557834 — intervention group
Group type: EXPERIMENTAL
Intervention: Andago
Number of subjects: 18
Study 33557844 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracile-based treatments (first- and second-line)
Number of subjects: 1
Study 33557844 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 1
Study 33557844 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment withdrawal and cancer progression
Number of subjects: 1
Study 33557844 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment
Number of subjects: 1
Study 33558093 — intervention group
Group type: EXPERIMENTAL
Intervention: Ideal body mass index (BMI)
Number of subjects: 2047
Study 33558093 — intervention group
Group type: EXPERIMENTAL
Intervention: Ideal physical activity
Number of subjects: 2047
Study 33558093 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-smoking
Number of subjects: 2047
Study 33558093 — intervention group
Group type: EXPERIMENTAL
Intervention: Ideal diet
Number of subjects: 2047
Study 33558093 — intervention group
Group type: COMPARATOR
Intervention: Smoking prevalence in females
Number of subjects: 2047
Study 33558093 — intervention group
Group type: COMPARATOR
Intervention: Physical activity in females
Number of subjects: 2047
Study 33558093 — intervention group
Group type: COMPARATOR
Intervention: Dietary habits in females
Number of subjects: 2047
Study 33558093 — intervention group
Group type: COMPARATOR
Intervention: Age-related smoking and diet prevalence
Number of subjects: 2047
Study 33558093 — intervention group
Group type: COMPARATOR
Intervention: BMI and diet in apprentices vs. academic students
Number of subjects: 2047
Study 33558093 — intervention group
Group type: COMPARATOR
Intervention: Smoking prevalence in apprentices
Number of subjects: 2047
Study 33558093 — intervention group
Group type: COMPARATOR
Intervention: Association of non-ideal BMI with smoking
Number of subjects: 2047
Study 33558125 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose cone-beam CT angiography (5-second rotation, n=45)
Number of subjects: 21
Study 33558125 — intervention group
Group type: COMPARATOR
Intervention: Standard cone-beam CT angiography (6-second rotation, n=29)
Number of subjects: 21
Study 33558152 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor plus acetylsalicylic acid (ASA)
Number of subjects: 154369
Study 33558152 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus acetylsalicylic acid (ASA)
Number of subjects: 154369
Study 33558152 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 154369
Study 33558163 — intervention group
Group type: EXPERIMENTAL
Intervention: Acknowledgement of healthcare professional (HCP) responsibility to contribute to weight loss
Number of subjects: 10854
Study 33558163 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfort in talking to their HCP about weight
Number of subjects: 10854
Study 33558163 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement that it is easy to lose weight
Number of subjects: 10854
Study 33558163 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal of reducing risks from excess weight
Number of subjects: 10854
Study 33558163 — intervention group
Group type: EXPERIMENTAL
Intervention: Consideration of obesity less important than other diseases
Number of subjects: 10854
Study 33558163 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise ≥5 times a week
Number of subjects: 10854
Study 33558202 — intervention group
Group type: EXPERIMENTAL
Intervention: Next-generation sequencing-based MRD assay
Number of subjects: 16
Study 33558239 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic risk scores for schizophrenia (GRSs) in the presence of early-life complications (ELCs)
Number of subjects: 0
Study 33558239 — intervention group
Group type: COMPARATOR
Intervention: Genomic risk scores for schizophrenia (GRSs) in the absence of early-life complications (ELCs)
Number of subjects: 0
Study 33558267 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolically Healthy Obese (MHO)
Number of subjects: 4381
Study 33558267 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolically Unhealthy (MUN and MUO)
Number of subjects: 4381
Study 33558294 — intervention group
Group type: EXPERIMENTAL
Intervention: Micafungin 8 mg/kg daily for a mean of 13.3 days (±5.2 days)
Number of subjects: 35
Study 33558294 — intervention group
Group type: EXPERIMENTAL
Intervention: Micafungin 8 mg/kg daily
Number of subjects: 35
Study 33558353 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual communication strategies (rational explanation, seduction, empathy)
Number of subjects: 38
Study 33558353 — intervention group
Group type: EXPERIMENTAL
Intervention: Confrontation or flight strategies
Number of subjects: 38
Study 33558353 — intervention group
Group type: EXPERIMENTAL
Intervention: Collective intervention for managing deviant behaviours
Number of subjects: 38
Study 33558353 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediators specialized in conflict resolution
Number of subjects: 38
Study 33558356 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient pulmonary rehabilitation programme
Number of subjects: 355
Study 33558436 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous belimumab 200 mg plus standard therapy
Number of subjects: 836
Study 33558436 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus standard therapy
Number of subjects: 836
Study 33558725 — intervention group
Group type: EXPERIMENTAL
Intervention: T cells engineered with a T cell receptor targeting HPV-16 E7
Number of subjects: 0
Study 33559089 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatic Steatosis Index (HSI)
Number of subjects: 394
Study 33559089 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonalcoholic Fatty Liver Disease Liver Fat Score (NAFLD-LFS)
Number of subjects: 394
Study 33559089 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglyceride Glucose (TyG) index
Number of subjects: 394
Study 33559089 — intervention group
Group type: EXPERIMENTAL
Intervention: Visceral Adiposity Index (VAI)
Number of subjects: 394
Study 33559286 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab treatment in DLBCL patients who are HBsAg positive
Number of subjects: 0
Study 33559286 — intervention group
Group type: COMPARATOR
Intervention: Rituximab treatment in DLBCL patients who are HBsAg negative
Number of subjects: 0
Study 33559346 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic heart failure with preserved ejection fraction (HFpEF)
Number of subjects: 81
Study 33559346 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic heart failure with reduced ejection fraction (HFrEF)
Number of subjects: 81
Study 33559346 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 81
Study 33559765 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV alternating with high-flow nasal oxygen
Number of subjects: 150
Study 33559765 — intervention group
Group type: COMPARATOR
Intervention: High-flow nasal oxygen alone
Number of subjects: 150
Study 33559777 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic B-lines score at a cut-off of 15
Number of subjects: 700
Study 33559777 — intervention group
Group type: EXPERIMENTAL
Intervention: B-profile pattern
Number of subjects: 700